Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > RBC now Rates Valeant Buy Target $231 US
View:
Post by TheRock07 on Oct 28, 2015 6:06am

RBC now Rates Valeant Buy Target $231 US

Nice to see
Comment by StocknerdEQcool on Oct 28, 2015 10:00am
yeah right if there are any more fools left. RBC and the banks can buy the stock themselves. Lol
Comment by freewest on Oct 28, 2015 10:11am
This post has been removed in accordance with Community Policy
Comment by health1234 on Oct 28, 2015 3:49pm
now stock green+9, keep your effrot to save canadian.